Acute stroke is a major socioeconomic burden in EU. The disabilities following the disease develop rapidly and prompt treatment of patients is imperative. Currently a drug dissolving the blood clot (rtPA - thrombolysis) is the only established treatment, but this is only implemented at highly specialised centres. There is consequently a strong geographical inequality in the availability of this treatment - nationally and internationally within EU.
At the same time there is an intense search by pharmaceutical industry and academic biomedical research to identify drugs that will stop the tissue damage progressing after acute stroke.
The knowledge discovery tool, I-Know will:
For further information, please visit:
http://www.cfin.au.dk
Project co-ordinator:
Dept. Neuroradiology, Aarhus Sygehus, Aarhus University Hospital, (DK)
Partners:
Timetable: from 05/06 to 04/09
Total cost: 3.876.347
EC funding: 3.092.810
Instrument: STREP
Project Identifier: IST-2004-027294
Microsoft in Healthcare and Life Sciences
Company Profiles:
Agfa HealthCare |
Carestream Health |
Cetrea |
CompuGroup Medical |
CSC |
CSW Group Ltd |
dbMotion |
Dell Healthcare and Life Sciences |
EMIS |
empirica |
First DataBank |
GE Healthcare |
IBM Healthcare |
Initiate Systems |
InterComponentWare AG (ICW) |
Intel in Healthcare |
InterSystems Corporation |
iPLATO Healthcare |
iSOFT |
Map of Medicine |
Oracle Healthcare Solutions |
Orion Health |
Philips Healthcare |
Picis |
SAP for Healthcare |
Siemens Healthcare |
System C Healthcare |
Telehealth Solutions |
Tieto |
Transinsight |
Toumaz |
Tunstall | ...